| Unleashing the therapeutic potential of human kallikrein-related serine proteases I Prassas, A Eissa, G Poda, EP Diamandis Nature reviews Drug discovery 14 (3), 183-202, 2015 | 246 | 2015 |
| Kallikrein-related peptidase-8 (KLK8) is an active serine protease in human epidermis and sweat and is involved in a skin barrier proteolytic cascade A Eissa, V Amodeo, CR Smith, EP Diamandis Journal of biological chemistry 286 (1), 687-706, 2011 | 108 | 2011 |
| Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions A Eissa, EP Diamandis Walter de Gruyter 389 (6), 669-680, 2008 | 100 | 2008 |
| Increasing SARS-CoV-2 vaccination rates among Black people in Canada A Eissa, A Lofters, N Akor, C Prescod, O Nnorom CMAJ 193 (31), E1220-E1221, 2021 | 43 | 2021 |
| Serum kallikrein-8 correlates with skin activity, but not psoriatic arthritis, in patients with psoriatic disease A Eissa, D Cretu, A Soosaipillai, A Thavaneswaran, F Pellett, ... Clinical Chemistry and Laboratory Medicine (CCLM) 51 (2), 317-325, 2013 | 39 | 2013 |
| Role of oxidative stress in the pathogenesis of vitiligo MI Helmy, EL Gayyar, S Hawas, AE Eissa J Pan-Arab League Dermatologist 15, 97-105, 2004 | 33 | 2004 |
| Proteinase-activated receptors (PARs): differential signalling by kallikrein-related peptidases KLK8 and KLK14 R Ramachandran, A Eissa, K Mihara, K Oikonomopoulou, M Saifeddine, ... Biological chemistry 393 (5), 421-427, 2012 | 30 | 2012 |
| Brief on primary care part 2: factors affecting primary care capacity in Ontario for pandemic response and recovery D Mangin, K Premji, I Bayoumi, N Ivers, A Eissa, S Newbery, ... Science Briefs of the Ontario COVID-19 Science Advisory Table 3, 68, 2022 | 18 | 2022 |
| Implementing high-quality primary care through a health equity lens A Eissa, R Rowe, A Pinto, GN Okoli, KM Campbell, JC Washington, ... The Annals of Family Medicine 20 (2), 164-169, 2022 | 12 | 2022 |
| Family physician practice patterns during COVID-19 and future intentions: Cross-sectional survey in Ontario, Canada T Kiran, R Wang, C Handford, N Laraya, A Eissa, P Pariser, R Brown, ... Canadian Family Physician 68 (11), 836-846, 2022 | 11 | 2022 |
| Brief on primary care part 3: lessons learned for strengthened primary care in the next phase of the COVID-19 pandemic N Ivers, S Newbery, A Eissa, I Bayoumi, T Kiran, A Pinto Science Briefs of the Ontario COVID-19 Science Advisory Table 3, 69, 2022 | 9 | 2022 |
| Best practices for COVID-19 mass vaccination clinics S Shakory, A Eissa, T Kiran, AD Pinto The Annals of Family Medicine 20 (2), 149-156, 2022 | 8 | 2022 |
| Keeping doors open: A cross-sectional survey of family physician practice patterns during COVID-19, needs, and intentions T Kiran, R Wang, C Handford, N Laraya, A Eissa, P Pariser, R Brown, ... medRxiv, 2021.12. 20.21267918, 2021 | 8 | 2021 |
| Brief on Primary Care Part 1: The roles of primary care clinicians and practices in the first two years of the COVID-19 pandemic in Ontario. Science Briefs of the Ontario COVID … T Kiran, A Eissa, D Mangin | 6 | 2022 |
| Planning and implementing COVID-19 mass vaccination clinics S Shakory, A Eissa, T Kiran, A Pinto | 4 | 2021 |
| Considerations for collecting data on race and Indigenous identity during health card renewal across Canadian jurisdictions AD Pinto, A Eissa, T Kiran, A Mashford-Pringle, A Needham, I Dhalla CMAJ 195 (25), E880-E882, 2023 | 3 | 2023 |
| Kallikrein-related peptidase 8 A Eissa, EP Diamandis Handbook of Proteolytic Enzymes, 2792-2798, 2013 | 2 | 2013 |
| Kallikrein protease involvement in skin pathologies supports a new view of the origin of inflamed itchy skin A Eissa, EP Diamandis Proteases and Their Receptors in Inflammation, 51-71, 2011 | 2 | 2011 |
| Kallikrein-related peptidases: an emerging family of pivotal players in epidermal desquamation and barrier function A Eissa, EP Diamandis Skin Moisturization, 143-166, 2016 | 1 | 2016 |
| Kallikrein-related Peptidase 14 A Eissa, EP Diamandis Handbook of Proteolytic Enzymes, 2809-2813, 2013 | 1 | 2013 |
